Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2

Details for Australian Patent Application No. 2002222513 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Inventors Rusnati, Marco; Bottazzi, Barbara; Mantovani, Alberto; Presta, Marco

Agent Davies Collison Cave

Pub. Number AU-B-2002222513

PCT Pub. Number WO02/38169

Priority RM200A000578 08.11.00 IT

Filing date 8 November 2001

Wipo publication date 21 May 2002

Acceptance publication date 26 October 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

26 October 2006 Application Accepted

  Published as AU-B-2002222513

23 November 2006 Corrigenda

  Applications Accepted - Name Index Under the name Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Application No. 2002222513, under INID (31) correct the priority number to RM2000A000578

22 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002222514-HEATING AND EMULSIFYING DEVICE

2002222512-ANCILLARY PROTECTION SYSTEM AGAINST THE UNAUTHORIZED USE OF AN ACCESS AND/OR IGNITION KEY